BetterLife Pharma (BETRF) Cash & Equivalents (2011 - 2026)
BetterLife Pharma (BETRF) posted Cash & Equivalents of $698,262 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with $16,130 a year earlier.
Powered by 
Analysis
BetterLife Pharma (BETRF) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Jan 31, 2026), BetterLife Pharma's Cash & Equivalents came in at $9,029, up 52.0% from FY2025.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -40.0% (FY2021 to FY2026).
- In prior fiscal years, BetterLife Pharma's Cash & Equivalents was $5,940 in FY2025 (-78.6%), $27,714 in FY2024 (+336.0%), $6,357 in FY2023 (-95.4%) and $138,535 in FY2022 (+19.7%).
- The fiscal Q2 2027 figure stands as the highest quarterly Cash & Equivalents since fiscal Q3 2022.
- On a year-over-year basis, Cash & Equivalents increased in two of the last six quarters, with an average decline of 37.3%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q4 2024, with growth of 349.0%; the weakest was fiscal Q2 2023, with a decline of 99.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.61 Bn | 1,101.20 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.68 Bn | 555.54 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 506.54 Bn | 479.65 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.37 Bn | 312.75 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.65 Bn | 256.64 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.69 Bn | 239.37 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.83 Bn | 193.23 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.33 Bn | 169.52 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn | 976.00 Mn |
| 10 | BetterLife Pharma | 24.80 Mn | 24.06 Mn | - | 694,867.71 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 694,867.71 |
| Apr 30, 2026 | 20,902.18 |
| Jan 31, 2026 | 9,316.63 |
| Jul 31, 2025 | 16,030.87 |
| Apr 30, 2025 | 13,739.98 |
| Jan 31, 2025 | 5,644.10 |
| Oct 31, 2024 | 13,426.09 |
| Jul 31, 2024 | 91,197.58 |
| Apr 30, 2024 | 309,403.89 |
| Jan 31, 2024 | 27,894.97 |
| Oct 31, 2023 | 66,975.69 |
| Jul 31, 2023 | 46,028.23 |
| Apr 30, 2023 | 181,970.20 |
| Jan 31, 2023 | 6,206.76 |
| Oct 31, 2022 | 30,611.18 |
| Jul 31, 2022 | 11,253.22 |
| Apr 30, 2022 | 11,249.08 |
| Jan 31, 2022 | 135,991.57 |
| Oct 31, 2021 | 1.73 Mn |
| Jul 31, 2021 | 3.41 Mn |
API Access
BetterLife Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BETRF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BETRF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BETRF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();